|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-10-19
|
|
pubmed:abstractText |
Atrophy of the stomach mucosa is considered to be premalignant lesion for gastric cancer development; easy identification of this condition from a blood-sample would allow identifying the group of individuals at increased risk for cancer development.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1573-2568
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2377-84
|
|
pubmed:meshHeading |
pubmed-meshheading:19731026-Aged,
pubmed-meshheading:19731026-Biological Markers,
pubmed-meshheading:19731026-Female,
pubmed-meshheading:19731026-Gastric Mucosa,
pubmed-meshheading:19731026-Gastrins,
pubmed-meshheading:19731026-Gastritis, Atrophic,
pubmed-meshheading:19731026-Gastroscopy,
pubmed-meshheading:19731026-Humans,
pubmed-meshheading:19731026-Latvia,
pubmed-meshheading:19731026-Lithuania,
pubmed-meshheading:19731026-Male,
pubmed-meshheading:19731026-Middle Aged,
pubmed-meshheading:19731026-Pepsinogen A,
pubmed-meshheading:19731026-Pepsinogen C,
pubmed-meshheading:19731026-Sensitivity and Specificity,
pubmed-meshheading:19731026-Taiwan
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology.
|
|
pubmed:affiliation |
Digestive Diseases Centre GASTRO, Riga Eastern Clinical University Hospital, University of Latvia, 6 Linezera iela, Riga 1006, Latvia. cei@latnet.lv
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|
